CANBD (CANBD) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 10 23 sessions, February 15, 2022 to March 21, 2022
- Largest daily move
- -26.7% close of February 22, 2022
Company Description
CANBD (OTC: CANBD) is classified in the drug manufacturers—specialty & generic industry within the Healthcare sector and carries a market capitalization of $11.8M.
CANBD has declined 17.3% over the past month. The last closing price was $6.20.
This page collects what Stock Titan holds for CANBD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CANBD (CANBD) closed at $6.20 on March 21, 2022. Over the past month, the price has lost 17.3%.
CANBD Metrics & Rankings
Price returns through March 21, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
CANBD has 10 recent news articles. Key topics include earnings, conferences. View all CANBD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CANBD Company Profile & Sector Positioning
CANBD (CANBD) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector.
Investors comparing CANBD often look at related companies in the same sector, including Vencanna Ventures (TPPRF), GENH (GENH), Therapeuticsmd Inc (TXMD), Flora Growth Corp (FLGC), and Im Cannabis Corp (IMCC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CANBD's relative position within its industry.